Combined application of polyacrylate scaffold and lipoic acid treatment promotes neural tissue reparation after brain injury

[EN] Primary objective: The aim of this study was to investigate the reparative potential of a polymeric scaffold designed for brain tissue repair in combination with lipoic acid. Research design: Histological, cytological and structural analysis of a combined treatment after a brain cryo-injury model in rats. Methods and procedures: Adult Wistar rats were subjected to cryogenic brain injury. A channelled-porous scaffold of ethyl acrylate and hydroxyethylacrylate, p(EA-co-HEA) was grafted into cerebral penumbra alone or combined with intraperitoneal LA administration. Histological and cytological evaluation was performed after 15 and 60 days and structural magnetic resonance (MRI) assessment was performed at 2 and 6 months after the surgery. Main outcomes and results: The scaffold was suitable for the establishment of different cellular types. The results obtained suggest that this strategy promotes blood vessels formation, decreased microglial response and neuron migration, particularly when LA was administrated. Conclusions: These evidences demonstrated that the combination of a channelled polymer scaffold with LA administration may represent a potential treatment for neural tissue repair after brain injury.The authors report no conflicts of interest. JMSL acknowledges funding through Programa de Ayudas a la Investigación Científica Universidad CEU-Cardenal Herrera (PRCEU-UCH 34/12), PRCEU-UCH 38/10 and programa ayudas a grupos consolidados 2014-15). CMR and MMP acknowledge financing through projects MAT2011-28791-C03-02 and ERA-NET NEURON project PRI-PIMNEU-2011-1372.Rocamonde, B.; Paradells, S.; Garcia Esparza, MA.; Sanchez Vives, M.; Sauro, S.; Martínez-Ramos, C.; Monleón Pradas, M.... (2016). Combined application of polyacrylate scaffold and lipoic acid treatment promotes neural tissue reparation after brain injury. Brain Injury. 30(2):208-216. https://doi.org/10.3109/02699052.2015.1091505S208216302Das, M., Mohapatra, S., & Mohapatra, S. S. (2012). New perspectives on central and peripheral immune responses to acute traumatic brain injury. Journal of Neuroinflammation, 9(1). doi:10.1186/1742-2094-9-236Jennett, B. (1972). Prognosis after Severe Head Injury. Neurosurgery, 19(CN_suppl_1), 200-207. doi:10.1093/neurosurgery/19.cn_suppl_1.200Kumar, S., Rao, S. L., Chandramouli, B. A., & Pillai, S. (2013). Reduced contribution of executive functions in impaired working memory performance in mild traumatic brain injury patients. Clinical Neurology and Neurosurgery, 115(8), 1326-1332. doi:10.1016/j.clineuro.2012.12.038Muehlschlegel, S., Carandang, R., Ouillette, C., Hall, W., Anderson, F., & Goldberg, R. (2013). Frequency and Impact of Intensive Care Unit Complications on Moderate-Severe Traumatic Brain Injury: Early Results of the Outcome Prognostication in Traumatic Brain Injury (OPTIMISM) Study. Neurocritical Care, 18(3), 318-331. doi:10.1007/s12028-013-9817-2Kaur, C., & Ling, E.-A. (2008). Antioxidants and Neuroprotection in the Adult and Developing Central Nervous System. Current Medicinal Chemistry, 15(29), 3068-3080. doi:10.2174/092986708786848640Helfaer MA, Kirsch JR, Traystman RJ. Radical scavenegers: penetration into brain following the ischemia and reperfusion. In: Krieglstein J O-S H, editor. Pharmacology of cerebral ischemia. Stuggart: Medpharma Scientific Publishers; 1994. p 297–309.Xia, W., Han, J., Huang, G., & Ying, W. (2010). Inflammation in ischaemic brain injury: Current advances and future perspectives. Clinical and Experimental Pharmacology and Physiology, 37(2), 253-258. doi:10.1111/j.1440-1681.2009.05279.xRocamonde, B., Paradells, S., Barcia, C., Garcia Esparza, A., & Soria, J. M. (2013). Lipoic Acid Treatment after Brain Injury: Study of the Glial Reaction. Clinical and Developmental Immunology, 2013, 1-8. doi:10.1155/2013/521939Rocamonde, B., Paradells, S., Barcia, J. M., Barcia, C., García Verdugo, J. M., Miranda, M., … Soria, J. M. (2012). Neuroprotection of lipoic acid treatment promotes angiogenesis and reduces the glial scar formation after brain injury. Neuroscience, 224, 102-115. doi:10.1016/j.neuroscience.2012.08.028Bokara, K. K., Kim, J. Y., Lee, Y. I., Yun, K., Webster, T. J., & Lee, J. E. (2013). Biocompatability of carbon nanotubes with stem cells to treat CNS injuries. Anatomy & Cell Biology, 46(2), 85. doi:10.5115/acb.2013.46.2.85Walker, P. A., Aroom, K. R., Jimenez, F., Shah, S. K., Harting, M. T., Gill, B. S., & Cox, C. S. (2009). Advances in Progenitor Cell Therapy Using Scaffolding Constructs for Central Nervous System Injury. Stem Cell Reviews and Reports, 5(3), 283-300. doi:10.1007/s12015-009-9081-1Ito, Y., Hasuda, H., Kamitakahara, M., Ohtsuki, C., Tanihara, M., Kang, I.-K., & Kwon, O. H. (2005). A composite of hydroxyapatite with electrospun biodegradable nanofibers as a tissue engineering material. Journal of Bioscience and Bioengineering, 100(1), 43-49. doi:10.1263/jbb.100.43Saracino, G. A. A., Cigognini, D., Silva, D., Caprini, A., & Gelain, F. (2013). Nanomaterials design and tests for neural tissue engineering. Chem. Soc. Rev., 42(1), 225-262. doi:10.1039/c2cs35065cBROWN, R., BLUNN, G., & EJIM, O. (1994). Preparation of orientated fibrous mats from fibronectin: composition and stability. Biomaterials, 15(6), 457-464. doi:10.1016/0142-9612(94)90225-9Ejim, O. S., Blunn, G. W., & Brown, R. A. (1993). Production of artificial-orientated mats and strands from plasma fibronectin: a morphological study. Biomaterials, 14(10), 743-748. doi:10.1016/0142-9612(93)90038-4Keilhoff, G., Stang, F., Wolf, G., & Fansa, H. (2003). Bio-compatibility of type I/III collagen matrix for peripheral nerve reconstruction. Biomaterials, 24(16), 2779-2787. doi:10.1016/s0142-9612(03)00084-xZhang, W., Chen, J., Tao, J., Jiang, Y., Hu, C., Huang, L., … Ouyang, H. W. (2013). The use of type 1 collagen scaffold containing stromal cell-derived factor-1 to create a matrix environment conducive to partial-thickness cartilage defects repair. Biomaterials, 34(3), 713-723. doi:10.1016/j.biomaterials.2012.10.027Martínez-Ramos, C., Lainez, S., Sancho, F., García Esparza, M. A., Planells-Cases, R., García Verdugo, J. M., … Soria, J. M. (2008). Differentiation of Postnatal Neural Stem Cells into Glia and Functional Neurons on Laminin-Coated Polymeric Substrates. Tissue Engineering Part A, 14(8), 1365-1375. doi:10.1089/ten.tea.2007.0295Soria, J. M., Martínez Ramos, C., Salmerón Sánchez, M., Benavent, V., Campillo Fernández, A., Gómez Ribelles, J. L., … Barcia, J. A. (2006). Survival and differentiation of embryonic neural explants on different biomaterials. Journal of Biomedical Materials Research Part A, 79A(3), 495-502. doi:10.1002/jbm.a.30803Xie, J., Willerth, S. M., Li, X., Macewan, M. R., Rader, A., Sakiyama-Elbert, S. E., & Xia, Y. (2009). The differentiation of embryonic stem cells seeded on electrospun nanofibers into neural lineages. Biomaterials, 30(3), 354-362. doi:10.1016/j.biomaterials.2008.09.046Wong, D. Y., Hollister, S. J., Krebsbach, P. H., & Nosrat, C. (2007). Poly(ɛ-Caprolactone) and Poly (L-Lactic-Co-Glycolic Acid) Degradable Polymer Sponges Attenuate Astrocyte Response and Lesion Growth in Acute Traumatic Brain Injury. Tissue Engineering, 13(10), 2515-2523. doi:10.1089/ten.2006.0440Martínez‐Ramos, C., Vallés‐Lluch, A., Verdugo, J. M. G., Ribelles, J. L. G., Barcia Albacar, J. A., Orts, A. B., … Pradas, M. M. (2012). Channeled scaffolds implanted in adult rat brain. Journal of Biomedical Materials Research Part A, 100A(12), 3276-3286. doi:10.1002/jbm.a.34273Rodríguez Hernández, J. C., Serrano Aroca, Á., Gómez Ribelles, J. L., & Pradas, M. M. (2008). Three-dimensional nanocomposite scaffolds with ordered cylindrical orthogonal pores. Journal of Biomedical Materials Research Part B: Applied Biomaterials, 84B(2), 541-549. doi:10.1002/jbm.b.30902Paxinos G, Watson C. The rat brain in stereotaxic coordinates. San Diego, CA: Academic Press; 1986.Harting, M. T., Sloan, L. E., Jimenez, F., Baumgartner, J., & Cox, C. S. (2009). Subacute Neural Stem Cell Therapy for Traumatic Brain Injury. Journal of Surgical Research, 153(2), 188-194. doi:10.1016/j.jss.2008.03.037Wallenquist, U., Brännvall, K., Clausen, F., Lewén, A., Hillered, L., & Forsberg-Nilsson, K. (2009). Grafted neural progenitors migrate and form neurons after experimental traumatic brain injury. Restorative Neurology and Neuroscience, 27(4), 323-334. doi:10.3233/rnn-2009-0481Sun, D., Gugliotta, M., Rolfe, A., Reid, W., McQuiston, A. R., Hu, W., & Young, H. (2011). Sustained Survival and Maturation of Adult Neural Stem/Progenitor Cells after Transplantation into the Injured Brain. Journal of Neurotrauma, 28(6), 961-972. doi:10.1089/neu.2010.1697Doetsch, F., Caillé, I., Lim, D. A., García-Verdugo, J. M., & Alvarez-Buylla, A. (1999). Subventricular Zone Astrocytes Are Neural Stem Cells in the Adult Mammalian Brain. Cell, 97(6), 703-716. doi:10.1016/s0092-8674(00)80783-7Fuentealba, L. C., Obernier, K., & Alvarez-Buylla, A. (2012). Adult Neural Stem Cells Bridge Their Niche. Cell Stem Cell, 10(6), 698-708. doi:10.1016/j.stem.2012.05.012Rice, A. (2003). Proliferation and neuronal differentiation of mitotically active cells following traumatic brain injury. Experimental Neurology, 183(2), 406-417. doi:10.1016/s0014-4886(03)00241-3Lee, C., & Agoston, D. V. (2010). Vascular Endothelial Growth Factor Is Involved in Mediating Increased De Novo Hippocampal Neurogenesis in Response to Traumatic Brain Injury. Journal of Neurotrauma, 27(3), 541-553. doi:10.1089/neu.2009.0905Sun, D., Bullock, M. R., Altememi, N., Zhou, Z., Hagood, S., Rolfe, A., … Colello, R. J. (2010). The Effect of Epidermal Growth Factor in the Injured Brain after Trauma in Rats. Journal of Neurotrauma, 27(5), 923-938. doi:10.1089/neu.2009.1209Verreck, G., Chun, I., Li, Y., Kataria, R., Zhang, Q., Rosenblatt, J., … Brewster, M. E. (2005). Preparation and physicochemical characterization of biodegradable nerve guides containing the nerve growth agent sabeluzole. Biomaterials, 26(11), 1307-1315. doi:10.1016/j.biomaterials.2004.04.040Park, K. I., Teng, Y. D., & Snyder, E. Y. (2002). The injured brain interacts reciprocally with neural stem cells supported by scaffolds to reconstitute lost tissue. Nature Biotechnology, 20(11), 1111-1117. doi:10.1038/nbt751Teng, Y. D., Lavik, E. B., Qu, X., Park, K. I., Ourednik, J., Zurakowski, D., … Snyder, E. Y. (2002). Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. Proceedings of the National Academy of Sciences, 99(5), 3024-3029. doi:10.1073/pnas.05267889

Biomaterials coated by dental pulp cells as substrate for neural stem cell differentiation

[EN] This study is focused on the development of an in vitro hybrid system, consisting in a polymeric biomaterial covered by a dental pulp cellular stroma that acts as a scaffold offering a neurotrophic support for the subsequent survival and differentiation of neural stem Cells. In the first place, the behavior of dental pulp stroma on the polymeric biomaterial based on ethyl acrylate and hydroxy ethyl acrylate copolymer was studied. For this purpose, cells from normal human third molars were grown onto 0.5-mm-diameter biomaterial discs. After cell culture, quantification of neurotrophic factors generated by the stromal cells was performed by means of an ELISA assay. In the second place, survival and differentiation of adult murine neural stem cells on the polymeric biomaterials covered by dental pulp stromal cells was studied. The results show the capacity of dental pulp cells to uniformly coat the majority of the material's surface and to secrete neurotrophic factors that become crucial for a subsequent differentiation of neural stem cells. The use of stromal cells cultured on scaffolding biomaterials provides neurotrophic pumps that may suggest new criteria for the design of cell therapy experiments in animal models to assist the repair of lesions in Central Nervous System.Contract grant sponsors: Programa de ayudas a la Investigacion cientifica Raman Areces; convenio de colaboracion entre el Instituto de Salud Carlos III, la Conselleria de Sanidad de la Generalitat Valenciana y la Fundacion de la Comunidad Valenciana Centro de Investigacion Principe Felipe para la investigacion basica y traslacional en medicina regenerativeSoria, JM.; Sancho-Tello, M.; Garcia Esparza, MA.; Mirabet, V.; Bagan, JV.; Monleón Pradas, M.; Carda, C. (2011). Biomaterials coated by dental pulp cells as substrate for neural stem cell differentiation. Journal of Biomedical Materials Research Part A. 97 A(1):85-92. https://doi.org/10.1002/jbm.a.33032S859297 A

30-Day morbidity and mortality of bariatric metabolic surgery in adolescence during the COVID-19 pandemic – The GENEVA study

Background: Metabolic and bariatric surgery (MBS) is an effective treatment for adolescents with severe obesity. Objectives: This study examined the safety of MBS in adolescents during the coronavirus disease 2019 (COVID-19) pandemic. Methods: This was a global, multicentre and observational cohort study of MBS performed between May 01, 2020, and October 10,2020, in 68 centres from 24 countries. Data collection included in-hospital and 30-day COVID-19 and surgery-specific morbidity/mortality. Results: One hundred and seventy adolescent patients (mean age: 17.75 ± 1.30 years), mostly females (n = 122, 71.8%), underwent MBS during the study period. The mean pre-operative weight and body mass index were 122.16 ± 15.92 kg and 43.7 ± 7.11 kg/m2, respectively. Although majority of patients had pre-operative testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (n = 146; 85.9%), only 42.4% (n = 72) of the patients were asked to self-isolate pre-operatively. Two patients developed symptomatic SARS-CoV-2 infection post-operatively (1.2%). The overall complication rate was 5.3% (n = 9). There was no mortality in this cohort. Conclusions: MBS in adolescents with obesity is safe during the COVID-19 pandemic when performed within the context of local precautionary procedures (such as pre-operative testing). The 30-day morbidity rates were similar to those reported pre-pandemic. These data will help facilitate the safe re-introduction of MBS services for this group of patients

30-Day Morbidity and Mortality of Bariatric Surgery During the COVID-19 Pandemic: a Multinational Cohort Study of 7704 Patients from 42 Countries.

BACKGROUND There are data on the safety of cancer surgery and the efficacy of preventive strategies on the prevention of postoperative symptomatic COVID-19 in these patients. But there is little such data for any elective surgery. The main objectives of this study were to examine the safety of bariatric surgery (BS) during the coronavirus disease 2019 (COVID-19) pandemic and to determine the efficacy of perioperative COVID-19 protective strategies on postoperative symptomatic COVID-19 rates. METHODS We conducted an international cohort study to determine all-cause and COVID-19-specific 30-day morbidity and mortality of BS performed between 01/05/2020 and 31/10/2020. RESULTS Four hundred ninety-nine surgeons from 185 centres in 42 countries provided data on 7704 patients. Elective primary BS (n = 7084) was associated with a 30-day morbidity of 6.76% (n = 479) and a 30-day mortality of 0.14% (n = 10). Emergency BS, revisional BS, insulin-treated type 2 diabetes, and untreated obstructive sleep apnoea were associated with increased complications on multivariable analysis. Forty-three patients developed symptomatic COVID-19 postoperatively, with a higher risk in non-whites. Preoperative self-isolation, preoperative testing for SARS-CoV-2, and surgery in institutions not concurrently treating COVID-19 patients did not reduce the incidence of postoperative COVID-19. Postoperative symptomatic COVID-19 was more likely if the surgery was performed during a COVID-19 peak in that country. CONCLUSIONS BS can be performed safely during the COVID-19 pandemic with appropriate perioperative protocols. There was no relationship between preoperative testing for COVID-19 and self-isolation with symptomatic postoperative COVID-19. The risk of postoperative COVID-19 risk was greater in non-whites or if BS was performed during a local peak

Safety of Bariatric Surgery in ≥ 65-Year-Old Patients During the COVID-19 Pandemic

Background Age >= 65 years is regarded as a relative contraindication for bariatric surgery. Advanced age is also a recognised risk factor for adverse outcomes with Coronavirus Disease-2019 (COVID-19) which continues to wreak havoc on global populations. This study aimed to assess the safety of bariatric surgery (BS) in this particular age group during the COVID-19 pandemic in comparison with the younger cohort.Methods We conducted a prospective international study of patients who underwent BS between 1/05/2020 and 31/10/2020. Patients were divided into two groups - patients >= 65-years-old (Group I) and patients < 65-years-old (Group II). The two groups were compared for 30-day morbidity and mortality.Results There were 149 patients in Group 1 and 6923 patients in Group II. The mean age, preoperative weight, and BMI were 67.6 +/- 2.5 years, 119.5 +/- 24.5 kg, and 43 +/- 7 in Group I and 39.8 +/- 11.3 years, 117.7 +/- 20.4 kg, and 43.7 +/- 7 in Group II, respectively. Approximately, 95% of patients in Group 1 had at least one co-morbidity compared to 68% of patients in Group 2 (p = < 0.001). The 30-day morbidity was significantly higher in Group I ( 11.4%) compared to Group II (6.6%) (p = 0.022). However, the 30-day mortality and COVID-19 infection rates were not significantly different between the two groups.Conclusions Bariatric surgery during the COVID-19 pandemic is associated with a higher complication rate in those >= 65 years of age compared to those < 65 years old. However, the mortality and postoperative COVID-19 infection rates are not significantly different between the two groups

Effect of BMI on safety of bariatric surgery during the COVID-19 pandemic, procedure choice, and safety protocols - An analysis from the GENEVA Study

Background: It has been suggested that patients with a Body Mass Index (BMI) of > 60 kg/m2 should be offered expedited Bariatric Surgery (BS) during the Coronavirus Disease-2019 (COVID-19) pandemic. The main objective of this study was to assess the safety of this approach. Methods: We conducted a global study of patients who underwent BS between 1/05/2020 and 31/10/2020. Patients were divided into three groups according to their preoperative BMI -Group I (BMI < 50 kg/m2), Group II (BMI 50-60 kg/m2), and Group III (BMI > 60 kg/m2). The effect of preoperative BMI on 30-day morbidity and mortality, procedure choice, COVID-19 specific safety protocols, and comorbidities was assessed. Results: This study included 7084 patients (5197;73.4 % females). The mean preoperative weight and BMI were 119.49 & PLUSMN; 24.4 Kgs and 43.03 & PLUSMN; 6.9 Kg/m2, respectively. Group I included 6024 (85 %) patients, whereas Groups II and III included 905 (13 %) and 155 (2 %) patients, respectively.The 30-day mortality rate was higher in Group III (p = 0.001). The complication rate and COVID-19 infection were not different. Comorbidities were significantly more likely in Group III (p = < 0.001). A significantly higher proportion of patients in group III received Sleeve Gastrectomy or One Anastomosis Gastric Bypass compared to other groups. Patients with a BMI of > 70 kg/m2 had a 30-day mortality of 7.7 % (2/26). None of these patients underwent a Roux-en-Y Gastric Bypass. Conclusion: The 30-day mortality rate was significantly higher in patients with BMI > 60 kg/m2. There was, however, no significant difference in complications rates in different BMI groups, probably due to differences in procedure selection